NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million Series D ...

NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will ...

After a year of layoffs and declining share prices in the wake of a late-stage clinical failure, Rain Oncology’s search for a suitable buyer has paid off. AI-focused Pathos AI will pay $1.16 per share ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Pathos AI has launched a $400 million funding round and ...

Two Tempus executives, including serial entrepreneur and billionaire Eric Lefkofsky, are behind a new drug discovery company in Chicago that's looking to raise $40 million. The startup, called Pathos ...

Pathos is a roguelike adventure game inspired by the rule set from Nethack. Choose from 13 classes and journey deep into the dungeon. Descend to hell to defeat your nemesis before escaping the dungeon ...

The Nasdaq Tower feature is a testament to Pathos Communications’ growth, innovation, and the increasing recognition of its unique business approach Supplied For many public relations firms, garnering ...